Title |
Minocycline exacerbates apoptotic neurodegeneration induced by the NMDA receptor antagonist MK-801 in the early postnatal mouse brain
|
---|---|
Published in |
European Archives of Psychiatry and Clinical Neuroscience, October 2015
|
DOI | 10.1007/s00406-015-0649-2 |
Pubmed ID | |
Authors |
Ioana Inta, Miriam A. Vogt, Anne S. Vogel, Markus Bettendorf, Peter Gass, Dragos Inta |
Abstract |
NMDA receptor (NMDAR) antagonists induce in perinatal rodent cortical apoptosis and protracted schizophrenia-like alterations ameliorated by antipsychotic treatment. The broad-spectrum antibiotic minocycline elicits antipsychotic and neuroprotective effects. Here we tested, if minocycline protects also against apoptosis triggered by the NMDAR antagonist MK-801 at postnatal day 7. Surprisingly, minocycline induced widespread cortical apoptosis and exacerbated MK-801-triggered cell death. In some areas such as the subiculum, the pro-apoptotic effect of minocycline was even more pronounced than that elicited by MK-801. These data reveal among antipsychotics unique pro-apoptotic properties of minocycline, raising concerns regarding consequences for brain development and the use in children. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 5 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 3 | 60% |
Unknown | 2 | 40% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 36 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 7 | 19% |
Student > Ph. D. Student | 6 | 17% |
Professor > Associate Professor | 4 | 11% |
Student > Doctoral Student | 3 | 8% |
Student > Bachelor | 2 | 6% |
Other | 5 | 14% |
Unknown | 9 | 25% |
Readers by discipline | Count | As % |
---|---|---|
Neuroscience | 9 | 25% |
Medicine and Dentistry | 7 | 19% |
Agricultural and Biological Sciences | 3 | 8% |
Biochemistry, Genetics and Molecular Biology | 3 | 8% |
Pharmacology, Toxicology and Pharmaceutical Science | 1 | 3% |
Other | 1 | 3% |
Unknown | 12 | 33% |